Search

Search Constraints

You searched for: Author/Creator Intini, Rossana

Search Results

1. A validated prognostic classifier for V600EBRAF-mutated metastatic colorectal cancer: the 'BRAF BeCool' study. (September 2019)

2. Another Chapter of the Right Versus Left Story: Is Primary Tumor Location a Prognostic Feature in RAS Mutant Metastatic Colorectal Cancer?. (17th August 2018)

3. Immunotherapy in Gastrointestinal Cancers. (3rd July 2017)

4. Prediction of Benefit from Checkpoint Inhibitors in Mismatch Repair Deficient Metastatic Colorectal Cancer: Role of Tumor Infiltrating Lymphocytes. (22nd January 2020)

5. Prognostic impact of early tumor shrinkage and depth of response in patients with microsatellite instability-high metastatic colorectal cancer receiving immune checkpoint inhibitors. Issue 4 (13th April 2021)

6. Prognostic impact of performance status on the outcomes of immune checkpoint inhibition strategies in patients with dMMR/MSI-H metastatic colorectal cancer. (September 2022)

7. The Pan-Immune-Inflammation Value in microsatellite instability–high metastatic colorectal cancer patients treated with immune checkpoint inhibitors. (June 2021)

8. The role of tumor angiogenesis as a therapeutic target in colorectal cancer. Issue 3 (4th March 2018)

9. Tumour mutational burden predicts resistance to EGFR/BRAF blockade in BRAF-mutated microsatellite stable metastatic colorectal cancer. (January 2022)